Abstract
Utilizing monoclonal antibodies to prevent and treat infectious diseases has been accelerated by the COVID-19 pandemic. In this issue of Cell Host & Microbe, Zheng et al. show how a three-monoclonal-antibody cocktail, that defies conventions of “rational design” for a therapeutic agent, functions cooperatively to disrupt coxsackievirus virions.
All Keywords
【초록키워드】 COVID-19 pandemic, monoclonal antibody, Infectious disease, therapeutic, function, coxsackievirus, treat, virions, Prevent, accelerated, disrupt, 【제목키워드】 antibody cocktail, coxsackievirus, disrupt,
【초록키워드】 COVID-19 pandemic, monoclonal antibody, Infectious disease, therapeutic, function, coxsackievirus, treat, virions, Prevent, accelerated, disrupt, 【제목키워드】 antibody cocktail, coxsackievirus, disrupt,